Loading provider…
Loading provider…
Specialist in San Francisco, CA
NPI: 1013086420Primary Practice Location
Pacific Hematology Oncology Assoc
2100 Webster St, San Francisco, CA
Primary Employer
Pacific Hematology Oncology Assoc
phoamd.com
HQ Phone
Get M.D. Ari's Phone Numberphone_androidMobile
Get M.D. Ari's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1991 - 2027
CA State Medical License

American Board of Internal Medicine
Medical Oncology
Tufts University School Of Medicine
medicine.tufts.edu
Medical School
Until 1990
University of California (San Francisco)/Fresno
Fellowship • Hematology and Medical Oncology
1994 - 1996
Wesleyan University
B.A. • English
Until 1984
UCSF School of Medicine
medschool.ucsf.edu
Internship • Internal Medicine
1990 - 1991
Residency • Internal Medicine
1991 - 1993
Authors: Richard Finn
Journal: Lancet
Authors: David Quinn, Elizabeth Guancial, Syed Hussain, Mark Fleming, Alexandra Drakaki, Ronac Mamtani, Clara Hwang, Jay Courtright, Edward Uchio
Journal: Lancet Oncol
Publication Date: 2021-05-26
Lead Sponsor: Bristol-Myers Squibb
Collaborators: Ono Pharmaceutical Co. Ltd
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Nivolumab
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, OTHER: Patient Observation
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Ipilimumab, OTHER: Quality-of-Life Assessment